QU; Fucheng
Patent Applications and Registrations
Patent applications and USPTO patent grants for QU; Fucheng.The latest application filed is for "glucagon-like peptide1 receptor agonists".
- QU; Fucheng - Carmel IN
- Qu, Fucheng - Lawrenceville NJ
| Patent | Date |
|---|---|
| Glucagon-like Peptide1 Receptor Agonists App 20200407347 - COATES; David Andrew ; et al. | 2020-12-31 |
| Pyrazole compounds Grant 9,296,775 - Qu March 29, 2 | 2016-03-29 |
| Novel Urea Compounds App 20140296171 - QU; Fucheng | 2014-10-02 |
| Urea compounds Grant 8,785,404 - Qu July 22, 2 | 2014-07-22 |
| Novel Pyrazole Compounds App 20140162967 - Qu; Fucheng | 2014-06-12 |
| Pyrazole compounds Grant 8,697,849 - Qu , et al. April 15, 2 | 2014-04-15 |
| Novel Urea Compounds App 20140100179 - QU; Fucheng | 2014-04-10 |
| Novel Pyrazole Compounds App 20130303471 - QU; Fucheng ; et al. | 2013-11-14 |
| FXR agonists Grant 7,846,960 - Bell , et al. December 7, 2 | 2010-12-07 |
| Fxr Agonists App 20090270460 - Bell; Michael Gregory ; et al. | 2009-10-29 |
| L-beta-dioxolane uridine analogs and methods for treating and preventing virus infections App 20010018440 - Chu, Chung K. ; et al. | 2001-08-30 |
| L-.beta.-dioxolane uridine analogs and their pharmaceutical compositions Grant 6,274,589 - Chu , et al. August 14, 2 | 2001-08-14 |
| L-.beta.-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections Grant 6,022,876 - Chu , et al. February 8, 2 | 2000-02-08 |
| L-.beta.-dioxolane uridine analog administration for treating Epstein-Barr virus infection Grant 5,792,773 - Chu , et al. August 11, 1 | 1998-08-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 